Molecular mechanisms of therapy-related myeloid neoplasms

The Department of the Army Medical Command awarded a $693,513 Project Grant to Brigham & Women's Hospital Inc. through the Military Medical Research and Development program. The grant will fund research into the molecular mechanisms of therapy-related myeloid neoplasms from September 30, 2022 to September 29, 2025.

As the stated purpose of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions, this award will likely support the Awardee's investigation into the underlying biological causes of therapy-related myeloid neoplasms. Findings could help the Army better understand and treat this condition, which sometimes arises in military personnel receiving medical treatments. The Awardee will leverage the three-year funding period to advance knowledge in this area and support the program's goal of developing medical solutions for service members.